Advancements and Treatment Options in Hepatocellular Carcinoma

This chapter explores recent updates on Hepatocellular Carcinoma (HCC), focusing on treatment-related mortality associated with doublet immunotherapy regimens. It also reviews the efficacy of various advanced treatment options like regorafenib and cabozantinib, while highlighting the importance of patient counseling on treatment risks and benefits.